News

The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer.

Meets untapped needs with release of new isogenic cell line.

Researchers have developed a speedy, controllable way to get two or more ingredients into the same tiny capsule and only have them mix when triggered by a signal like vibrations or heat.

First trials of smart gas sensing pills reveal how low & high-fiber diets affect gut.

McMaster University researchers have taken a giant leap in identifying the early stages of a deadly cancer and predicting how it will develop in individuals.

Collaboration to investigate the combination of KEYTRUDA (pembrolizumab) and BL-8040 in pancreatic cancer.

NIH study finds no reason for delaying pregnancy attempts after a loss without complications.

New collaboration to provide warp drive funding and milestones in excess of $750 million.

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.

Tensha Therapeutics, a privately-held company based in Cambridge, MA, has announced it will be acquired by Roche.